BridgeBio
BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.
8
Funding Rounds
$1.6b
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Fr*** Mc******* | - | - | |
| Ne** Ku*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne** Ku*** | - | - | |
| Br***** L. Sa****** | - | - | linkedin twitter instagram |
| Ha**** Va******* | - | - | |
| An**** El*** | - | - | - |
| Do***** Da****** | - | - | |
| Ra*** Sc*** |
|
- | |
| Je****** Co** | - | - | |
| Er** Ag**** | - | - | - |
| Ch***** Ho*** | - | - | - |
| Fr** Ha**** | - | - | - |
| Ri***** Sc****** | - | - | - |
| Ro**** J. Da***** | - | - | - |
| An**** Lo | - | - | - |
| Ja*** Mo****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company BridgeBio has raised a total of $1.38b in funding over 8 rounds.
Key Insights:
- BridgeBio Venture round, March 2020: $475m
- BridgeBio Pharma , January 2019: $299m
- BridgeBio Series D round, January 2019: $299.2m
- BridgeBio Pharma , September 2017: $135m
- BridgeBio Series C round, September 2017: $135m
- BridgeBio Series B round, May 2017: $33.1m
- BridgeBio Series B round, March 2016: $6.9m
- BridgeBio Venture round, January 2021: $250m
BridgeBio Venture round, March 2020
$475m
BridgeBio Pharma , January 2019
$299m
BridgeBio Series D round, January 2019
$299.2m
BridgeBio Pharma , September 2017
$135m
BridgeBio Series C round, September 2017
$135m
BridgeBio Series B round, May 2017
$33.1m
BridgeBio Series B round, March 2016
$6.9m
BridgeBio Venture round, January 2021
$250m
Industries
BridgeBio is active in the following industries:
- Immunotherapy
- Genealogy
- Genetics
- Pharmaceutical industry
- Biomedical engineering
- Enzyme kinetics
- Chemistry
- Technology
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Tissue engineering
- Microbiology
- Cell therapy
- Engineering
- Synthetic chemistry
Subsidiaries
BridgeBio operates through the following subsidiaries:
